Diageo PLC
4 March 2002
TO: Regulatory News Service
The London Stock Exchange
RE: CHAPTER 16 PARAGRAPH 13 OF
CONTINUING OBLIGATIONS
Diageo plc (the 'Company') announces the following:
1. That it received notification on 4 March 2002 for the purposes of Section 329
of the Companies Act 1985 of transactions by the trustee of the Diageo Employee
Benefit Trust (the 'Employee Benefit Trust') as detailed below. The Employee
Benefit Trust is a discretionary trust for the benefit of employees of the
Company and its subsidiaries and operates primarily in conjunction with the
Company's Long Term Incentive Plan, now called the Total Shareholder Return plan
(the 'Plan'), approved by shareholders on 11 August 1998.
a) A notification that Mourant & Co Trustees Limited ('Mourant') as trustee of
the Employee Benefit Trust had transferred ordinary shares of 28 101/108 pence
of the Company ('Ordinary Shares') to participants receiving awards released
under the Plan on 27 February 2002 and 1 March 2002 as follows:
Date of Transaction No of Ordinary
Shares
27.02.02 2,400
01.03.02 202,650
which includes Ordinary Shares released to executive directors of the Company,
as announced to the London Stock Exchange on 1 March 2002.
b) A notification that Mourant, as trustee of the Employee Benefit Trust, had
made the following sale of Ordinary Shares:
Date of Transaction No of Ordinary Sale Price of Ordinary
Shares Sold Shares
01.03.02 82,942 £8.47
which includes Ordinary Shares sold on behalf of executive directors of the
Company to meet the requirement to reimburse the Company for the PAYE tax
liability, as follows:
Name of Director No. of Ordinary Shares Sale Price of Ordinary Shares
N C Rose 6,550 £8.47
P S Walsh 35,231 £8.47
c) Both executive directors of the Company are potential beneficiaries of the
Employee Benefit Trust, as follows;
N C Rose
P S Walsh
d) As a result of the above transactions the total holding of the Employee
Benefit Trust amounts to 3,740,959 Ordinary Shares.
2. That Mr N C Rose, a director, notified the Company on 4 March 2002 that:
a) on 1 March 2002, he exercised options over 20,000 Ordinary Shares granted on
13 June 1995 at a price per share of £4.02 and 37,802 Ordinary Shares granted on
12 June 1996 at a price per share of £4.29, all granted under the Company's
Executive Option Schemes.
b) on 1 March 2002, he sold 37,802 Ordinary Shares at a price per share of
£8.705.
3. As a result of the transactions reported in paragraphs 1. b) and 2. above,
the interests of the Company's executive directors in Ordinary Shares (excluding
options, awards under the Company's LTIPs and also interests as potential
beneficiaries of the Diageo Employee Benefit Trust, the Diageo plc QUEST, the
Diageo 2001 All Employee Share Ownership Plan, the Grand Metropolitan No.2
Employee Share Trust and, in the case of Mr Walsh only, the Pillsbury 401 (K)
Savings Plan) are as follows:
Name of Director No. of Ordinary Shares
N C Rose 82,430
P S Walsh 439,985*
*of which 4,932 are held in the form of ADSs.
4 March 2002
This information is provided by RNS
The company news service from the London Stock Exchange
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.